News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Abbott Laboratories to Cut 3,000 Jobs Following Solvay Pharmaceuticals, Inc. Deal
September 21, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK, Sept 21 (Reuters) - Abbott Laboratories Inc (ABT.N) plans to cut 3,000 jobs, or about 3 percent of its workforce, following its purchase of Solvay's (SOLB.BR) pharmaceuticals business.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
People
MORE ON THIS TOPIC
Job Trends
Posers and Pretenders: Interview Fraud Rising, Experts Say
October 23, 2025
·
5 min read
·
Angela Gabriel
Job Trends
8 Companies Hiring Now in Regulatory
October 23, 2025
·
2 min read
·
Angela Gabriel
Job Trends
Most Employers Consider Hiring but Worry About Overqualified Job Candidates: Survey
October 22, 2025
·
3 min read
·
Angela Gabriel
C-suite
Novo Foundation Replaces Pharma’s Board, Revealing Deep Divisions Over Leadership
October 21, 2025
·
4 min read
·
Annalee Armstrong
